Maria Tsoli

Children's Cancer Institute Australia, UNSW Sydney

Affiliated withUNSW Sydney

Research Area

Cancer Research

Biography

Maria Tsoli has not added Biography.
If you are Maria Tsoli and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma. British journal of cancer\| PubMed ID: 30220707	2018
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas. Nature communications\| PubMed ID: 33579942	2021
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell reports\| PubMed ID: 33852836	2021
The important role of routine cytopathology in pediatric precision oncology. Cancer cytopathology\| PubMed ID: 34043284	2021
Parents' experiences of postmortem tumor donation for high-grade gliomas: benefits and suggested improvements. Neuro-oncology advances\| PubMed ID: 34458732	2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer. EMBO molecular medicine\| PubMed ID: 34927798	2022
Therapeutic Targets in Diffuse Midline Gliomas-An Emerging Landscape. Cancers\| PubMed ID: 34944870	2021
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy. Theranostics\| PubMed ID: 35832071	2022
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer. Advanced drug delivery reviews\| PubMed ID: 36931346	2023
loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma. Frontiers in oncology\| PubMed ID: 36937401	2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities. Cancer cell\| PubMed ID: 37001527	2023
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer. Cancer research\| PubMed ID: 37523146	2023
Microtubule-Targeting Combined with HDAC Inhibition Is a Novel Therapeutic Strategy for Diffuse Intrinsic Pontine Gliomas. Molecular cancer therapeutics\| PubMed ID: 37683275	2023
From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients. Biomedicines\| PubMed ID: 38001908	2023
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma. The Journal of clinical investigation\| PubMed ID: 38319732	2024
Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomas. Neuro-oncology advances\| PubMed ID: 38550394	2024
Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 38676797	2024
Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Neuro-oncology\| PubMed ID: 40072012	2025